What is Wegovy and what does it treat? BBC documentary to investigate weight-loss jab
Share:
Panorama is to shine a light on the use of weight loss medication in the UK. The BBC investigation programme will look at the anti-obesity drugs that are being widely used across Britain and ask the question: “Are they the answer long term?”. Airing on Monday (January 13) at 8pm the programme will look at those using them, plus getting expert opinions on the use of drugs such as Wegovy.
The programme synopsis states: “A new generation of anti-obesity drugs are being hailed as game changers for the NHS and for millions of patients. So-called 'skinny jabs' like Wegovy have largely been the preserve of celebrities and those with the money to buy them privately, but now the NHS is beginning to roll them out. So will they live up to the hype, how available will they be, and is the NHS ready for a revolution in treating obesity?”.
![[More info needed on weight-loss jab’s impact on type 2 diabetes – Nice]](https://static.standard.co.uk/2023/06/27/00/a36a0897757ddb95fccf5c307910103fY29udGVudHNlYXJjaGFwaSwxNjg3ODgwNzk1-2.71578970.jpg?crop=8:5,smart&quality=75&auto=webp&width=960)
It has been claimed anti-obesity jabs could reduce the risk of heart attacks and strokes in people even if they fail to lose much weight, according to a study funded by a drug manufacturer. The five-year study looked at semaglutide – a prescription drug offered by the NHS – that works by suppressing appetite and is sold under the brand names Wegovy and Ozempic. The trial was run by Novo Nordisk, the Danish company that manufactures Ozempic, and is yet to be peer-reviewed. The study said the weekly shots could also benefit cardiovascular health.
![[Berberine — nature’s Ozempic or health food fad?]](https://static.standard.co.uk/2023/02/24/10/newFile-7.jpg?crop=8:5,smart&quality=75&auto=webp&width=960)
